ARTICLE | Distillery Therapeutics
Endocrine/metabolic
October 11, 2018 10:59 PM UTC
Mouse studies suggest base editing-mediated knockout of HPD could help treat tyrosinemia type I, which is caused by mutations in FAH downstream of HPD. In an in utero mouse model of the disease harbor...
BCIQ Target Profiles